Press release
A Nanobiotechnology Startup from a small town in India attracts the Global Investors.
Summary :Ariviya, a Nanotechnology Biotechnology Startup from a small town Pattukkottai in the State of Tamil Nadu, India who is developing a product called MammaryO to prevent a costly disease "Mastitis" in dairy cows at big dairy farms, attracts global investors in Tamil Nadu Global Investor Meet 2019.
Full Article :
Ariviya, a Nanotechnology Biotechnology Startup from a small town Pattukkottai in the State of Tamil Nadu, India who is developing a product called MammaryO to prevent a costly disease "Mastitis" in dairy cows at big dairy farms, attracts global investors in Tamil Nadu Global Investor Meet 2019.
Bovine mastitis is the costliest problem for dairy farmers all over the world. Annual loss due to Mastitis is 2 Billion USD in the US, 1.5 billion USD in Europe and 2.2 billion USD in India. Mastitis reduces milk production in the US by 11% and in India by 21%. Mastitis causes 70% of all avoidable losses during milk production. Mastitis is ranked second after infertility as the main reason for culling(slaughtering) cows. 20-50% of dairy cows treated for Mastitis in Europe and the USA.
Dr. Siva, Chief Technology Officer of Ariviya, said: "MammaryO is a natural, organic, thick Nano-Bio liquid foam covering and protecting the cow teats from bacterial infection and reduces the spread of organism which may cause Bovine Mastitis, lasts long enough in the cow teat until next milking, easily washable and biodegradable."
"The price per gallon goes up if you have less number of SCC(Somatic Cell Count) in your milk, but if your cow has Mastitis then this SCC number goes up, and price per gallon comes down. Preventing Mastitis means, doing business" said a seasoned dairy farm owner at Hyderabad, Telangana, India.
Current mastitis treatment is very inefficient. Mastitis is detected from visible swelling, abnormal milk, and rise in somatic cell count. Sick cows get separated from the rest of the cows for weeks then they undergo antibiotic treatment. For a long period, the cow can’t be milked because the antibiotics are unsafe for human consumption.
“Global investors see the value in what we are doing, the science behind our product, market size, demand and shows interest in joining us to scale our product to the next level," said Dr. Siva.
The Startup scene in the third tier cities and small towns are changing very fast, a lot of innovations happening here which can address the real problems. The founders of these small town Startups have a background which helps them to understand the problem deep and fast. Dr. Siva itself from the dairy farming family background but did his Ph.D. and researches in Singapore and Japan before founding Ariviya in his home town in India, no wonder how these small towns Startup attracts global investors.
About Ariviya Inc
Arivya is inventing Nanobiotechnology solutions for problems in human wellness, animal wellness, agriculture, infrastructures. For example, Bovine Mastitis, Wound healing, Seed protection, Second-degree burn, Water purification, Seed coating, etc. At Ariviya we apply Lean methodology in technical research, product development, and commercialization.
Contact Details
Ariviya Inc
80/73 Chinnaiya St, Pattukkottai, Thanjavur, Tamil Nadu, India, 614602
Email : Press@Ariviya.com
Phone : +91 63827 81414
www.Ariviya.com
www.facebook.com/AriviyaLabs
www.twitter.com/AriviyaLabs
About Ariviya Inc
Arivya is inventing Nanobiotechnology solutions for problems in human wellness, animal wellness, agriculture, infrastructures. For example, Bovine Mastitis, Wound healing, Seed protection, Second-degree burn, Water purification, Seed coating, etc. At Ariviya we apply Lean methodology in technical research, product development, and commercialization.
80/73, Chinnaiya St
Pattukkottai, Thanjavur, Tamil Nadu, India, 614602
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A Nanobiotechnology Startup from a small town in India attracts the Global Investors. here
News-ID: 1535438 • Views: …
More Releases for Mastitis
Bovine Mastitis Market Is Booming So Rapidly | Neogen, Vetoquinol, Dechra
The "Bovine Mastitis Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bovine Mastitis Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Zoetis,…
Bovine Mastitis Market to Witness Stunning Growth | Elanco, Ceva, Virbac
A new business intelligence report released by USD Analytics with title "Global Bovine Mastitis Market Report 2030 " has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The Global Bovine Mastitis Market Report offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary…
Bovine Mastitis Market: Current Trends and Future Prospects
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
• CAGR: 6.3%
• Current Market Size: USD 0.54 Billion
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988
Bovine mastitis, an inflammatory condition of the mammary gland in dairy cows, poses…
Global Bovine Mastitis Market: Prevalence, Challenges, and Opportunities
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
• CAGR: 6.3%
• Current Market Size: USD 0.54 Billion
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988
Bovine mastitis is a prevalent and economically significant disease affecting dairy cattle worldwide.…
Emerging Therapies and Innovations in the Bovine Mastitis Market
Bovine mastitis, a common and costly disease affecting dairy cattle, continues to be a significant challenge for the dairy industry worldwide. It is characterized by inflammation of the udder tissue, leading to reduced milk production, decreased milk quality, and increased treatment costs.
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022…
Demand for Safe and Quality Milk Boosts Bovine Mastitis Market
Bovine mastitis is a common and serious disease that affects dairy cows. It is an inflammatory response of the udder tissue, caused by bacteria or other pathogens that infect the cow's mammary gland. Mastitis can cause milk production to decrease, and the milk produced can be of poor quality and even unsafe for human consumption.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 2023: https://www.alliedmarketresearch.com/request-sample/17988
The bovine mastitis market was valued at…